| Identification | Back Directory | [Name]
N-[2-(diethylamino)ethyl]-N-(2-{[2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl]amino}ethyl)-3-[2-(naphthalen-1-yl)ethoxy]propanamide | [CAS]
925243-19-2 | [Synonyms]
AZD3199
AZD-3199
AZD 3199
AZD-3199 free base
AZD3199 free base,AZD 3199 free base
N-[2-(diethylamino)ethyl]-N-(2-{[2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl]amino}ethyl)-3-[2-(naphthalen-1-yl)ethoxy]propanamide | [EINECS(EC#)]
642-932-6 | [Molecular Formula]
C32H42N4O4S | [MOL File]
925243-19-2.mol | [Molecular Weight]
578.765 |
| Hazard Information | Back Directory | [Uses]
AZD-3199 is an ultra-long-acting beta2 agonist with potential activity against asthma and chronic obstructive pulmonary disease[1]. | [References]
[1] Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA) |
|
|